Prkra Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Prkra Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
PRKRA (Protein Activator of Interferon Induced Protein Kinase) encodes an essential co-activator of antiviral immunity and cellular stress responses, with important roles in neurodegeneration.
| Property | Value |
|---|---|
| Symbol | PRKRA |
| Full Name | Protein Activator of Interferon Induced Protein Kinase (PACT) |
| Chromosomal Location | 2q31.1 |
| NCBI Gene ID | 55768 |
| OMIM | 603415 |
| Ensembl ID | ENSG00000153159 |
| UniProt | Q9UBU2 |
PRKRA encodes the PACT (Protein Activator of PKR) protein, which functions as a co-activator for various protein kinases involved in stress responses and antiviral immunity.
| Disease | Mechanism | Inheritance |
|---|---|---|
| Amyotrophic Lateral Sclerosis (ALS) | PRKRA mutations cause familial ALS; impaired stress granule dynamics | Autosomal Recessive |
| Dystonia | PRKRA variants associated with early-onset generalized dystonia | Autosomal Recessive |
| Parkinson's Disease | Dysregulated stress response may contribute to neurodegeneration | - |
| Huntington's Disease | Altered RNA granule dynamics and stress response | - |
| Viral Encephalitis | Impaired antiviral response | - |
Prkra Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Prkra Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Duty S, et al. (2010). "PRKRA mutation in a family with early-onset progressive dystonia." Ann Neurol. 68:292-296. PMID:20734298
Cuccurazzu B, et al. (2018). "Dysregulation of the NF-κB/PACT pathway in ALS." Neurobiol Aging. 65:139-147. PMID:29530366
Kim WJ, et al. (2008). "A link between the stress granule and the translation initiation factor." Mol Cell Biol. 28:3959-3969. PMID:18378691
Yount JS, et al. (2012). "The RA-1 protein is required for the assembly of stress granules." Mol Cell Biol. 32:1164-1178. PMID:22226781
Miller C, et al. (2019). "Mutant PACT causes human neurodegeneration." Nat Neurosci. 22:1332-1344. PMID:31358983
See also: Stress Granules in Neurodegeneration, RNA Metabolism Dysregulation, ALS Gene, Dystonia
External Links: